Global Cardiac Marker Testing Market Report 2024

Cardiac Marker Testing Global Market Report 2024 – By Product (Reagents And Kits, Instruments), By Biomarker Type (Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers), By Application (Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions) – Market Size, Trends, And Global Forecast 2024-2033

Cardiac Marker Testing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Cardiac Marker Testing Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Cardiac Marker Testing Market Definition

Cardiac marker testing refers to a series of diagnostic tests used to measure specific substances in the blood that can indicate damage or stress to the heart. These markers are often proteins or enzymes released into the bloodstream when the heart muscle is injured. Cardiac marker tests are crucial for diagnosing and evaluating conditions such as myocardial infarction (heart attack), heart failure, and other cardiac diseases.

The main cardiac marker testing products are reagents, kits, and instruments. Reagents and kits are essential components used in cardiac marker testing that contain the necessary chemicals and materials required to perform diagnostic tests. It provides various types of biomarkers, including troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and others, and it is applied in laboratory testing facilities, point-of-care testing facilities, and academic institutions.

Cardiac Marker Testing Market Segmentation

The cardiac marker testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments

2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers

3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions

Global Cardiac Marker Testing Market Size 2023 to 2028: Graph

Cardiac Marker Testing Market Size 2024 And Growth Rate

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $5.92 billion in 2023 to $6.52 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rise in geriatric population, rise in educational campaigns, increasing awareness, rising healthcare infrastructure, and rising patient population.

Cardiac Marker Testing Market Growth Forecast

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising incidences of cardiovascular diseases, increasing strategic collaborations and partnerships, increasing research and development initiatives, favorable reimbursement policies and rising demand for point-of-care (POC) testing. Major trends in the forecast period include advanced diagnostic technologies, automated analyzers, advanced cardiac marker testing assays, digital health technologies, and emergence of integrative technologies.

Cardiac Marker Testing Market Driver: Rising Cardiovascular Disease Incidence Fuels Growth In Cardiac Marker Testing Market

The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac marker testing market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The rising cases of cardiovascular diseases are caused due to an unhealthy diet, physical inactivity, tobacco use, harmful use of alcohol, and air pollution. Cardiac marker testing is required for cardiovascular diseases to accurately diagnose, assess the severity, and monitor the progression or response to treatment of heart conditions by detecting specific biomarkers released during myocardial injury. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 when compared to 2023. Sudden cardiac arrest was responsible for 20,114 deaths in the U.S. in 2021. Therefore, the rising incidence of cardiovascular diseases drives the cardiac marker testing market.

Global Cardiac Marker Testing Market Major Players

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

Global Cardiac Marker Testing Market Trend: Advancements In Cardiac Marker Testing

Major companies operating in the cardiac marker testing market are focused on developing technologically advanced products, such as cardiac assays, to provide valuable, precise information about heart health and function. Cardiac assays are diagnostic tests designed to measure biomarkers or other indicators in the blood or other samples to assess heart function, diagnose cardiovascular diseases, or evaluate the risk of heart-related conditions. For instance, in October 2023, Mindray, a China-based medical device company, launched the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay distinguishes itself with exceptional sensitivity, precision, and reliability, surpassing minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL) and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL, making it highly effective in detecting myocardial injury. Mindray's NT-proBNP assay is an important cardiac marker for heart failure, showing high precision with a coefficient of variation (CV) of =5%. It also effectively minimizes interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.

Cardiac Marker Testing Market Merger And Acquisition: VION Biosciences Acquires Ansh Labs To Strengthen Diagnostic Market Presence And Expand Product Offerings

In August 2024, VION Biosciences, a US-based life sciences platform acquired Ansh Labs for an undisclosed amount. Through this acquisition, VION Biosciences aims to strengthen its presence in the diagnostic sector, integrate advanced technologies, and expand its product offerings in immunoassay development. Ansh Labs is a US-based biotechnology company.

Regional Insights For The Global Cardiac Marker Testing Market

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiac Marker Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $ 2.68 Billion
Revenue Forecast In 2033 $ 4.74 Billion
Growth Rate CAGR of 15.40% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cardiac Marker Testing Market Characteristics

    3. Cardiac Marker Testing Market Trends And Strategies

    4. Cardiac Marker Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Cardiac Marker Testing Market Size and Growth

    5.1. Global Cardiac Marker Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cardiac Marker Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cardiac Marker Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cardiac Marker Testing Market Segmentation

    6.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Reagents And Kits

    Instruments

    6.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Troponin I And T

    Creatine Kinase-MB (CK-MB)

    Natriuretic Peptide

    Myoglobin

    High-Sensitivity C-Reactive Protein

    Other Cardiac Biomarkers

    6.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Laboratory Testing Facilities

    Point-Of-Care Testing Facilities

    Academic Institutions

    7. Cardiac Marker Testing Market Regional And Country Analysis

    7.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cardiac Marker Testing Market

    8.1. Asia-Pacific Cardiac Marker Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cardiac Marker Testing Market

    9.1. China Cardiac Marker Testing Market Overview

    9.2. China Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cardiac Marker Testing Market

    10.1. India Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cardiac Marker Testing Market

    11.1. Japan Cardiac Marker Testing Market Overview

    11.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cardiac Marker Testing Market

    12.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cardiac Marker Testing Market

    13.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cardiac Marker Testing Market

    14.1. South Korea Cardiac Marker Testing Market Overview

    14.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cardiac Marker Testing Market

    15.1. Western Europe Cardiac Marker Testing Market Overview

    15.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cardiac Marker Testing Market

    16.1. UK Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cardiac Marker Testing Market

    17.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cardiac Marker Testing Market

    18.1. France Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cardiac Marker Testing Market

    19.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cardiac Marker Testing Market

    20.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cardiac Marker Testing Market

    21.1. Eastern Europe Cardiac Marker Testing Market Overview

    21.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cardiac Marker Testing Market

    22.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cardiac Marker Testing Market

    23.1. North America Cardiac Marker Testing Market Overview

    23.2. North America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cardiac Marker Testing Market

    24.1. USA Cardiac Marker Testing Market Overview

    24.2. USA Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cardiac Marker Testing Market

    25.1. Canada Cardiac Marker Testing Market Overview

    25.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cardiac Marker Testing Market

    26.1. South America Cardiac Marker Testing Market Overview

    26.2. South America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cardiac Marker Testing Market

    27.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cardiac Marker Testing Market

    28.1. Middle East Cardiac Marker Testing Market Overview

    28.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cardiac Marker Testing Market

    29.1. Africa Cardiac Marker Testing Market Overview

    29.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

    30.1. Cardiac Marker Testing Market Competitive Landscape

    30.2. Cardiac Marker Testing Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Abbott Laboratories

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Danaher Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Siemens Healthineers AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Cardiac Marker Testing Market Other Major And Innovative Companies

    31.1. Becton Dickinson and Company

    31.2. Laboratory Corporation of America Holdings

    31.3. Quest Diagnostics Inc.

    31.4. Tosoh Corporation

    31.5. bioMérieux SA

    31.6. Sysmex Corporation

    31.7. Bio-Rad Laboratories Inc.

    31.8. Guangzhou Wondfo Biotech Co. Ltd.

    31.9. Randox laboratories Ltd.

    31.10. Getein Biotech Inc.

    31.11. Fujirebio Inc.

    31.12. Mayo Clinic Laboratories

    31.13. Kainos Medicine Inc.

    31.14. Alere Inc.

    31.15. Nano-Ditech Corporation

    32. Global Cardiac Marker Testing Market Competitive Benchmarking

    33. Global Cardiac Marker Testing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

    35. Cardiac Marker Testing Market Future Outlook and Potential Analysis

    35.1 Cardiac Marker Testing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Cardiac Marker Testing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Cardiac Marker Testing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Abbott Laboratories Financial Performance
  • Figure 77: Danaher Corporation Financial Performance
  • Figure 78: Siemens Healthineers AG Financial Performance

List Of Figures

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Abbott Laboratories Financial Performance
  • Table 77: Danaher Corporation Financial Performance
  • Table 78: Siemens Healthineers AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the cardiac marker testing market?

Cardiac marker testing refers to a series of diagnostic tests used to measure specific substances in the blood that can indicate damage or stress to the heart. These markers are often proteins or enzymes released into the bloodstream when the heart muscle is injured. Cardiac marker tests are crucial for diagnosing and evaluating conditions such as myocardial infarction (heart attack), heart failure, and other cardiac diseases. For further insights on the cardiac marker testing market, request a sample here

How will the cardiac marker testing market drivers and restraints affect the cardiac marker testing market dynamics? What forces will shape the cardiac marker testing industry going forward?

The cardiac marker testing market major growth driver - Rising Cardiovascular Disease Incidence Fuels Growth In Cardiac Marker Testing Market. For further insights on the cardiac marker testing market, request a sample here

What is the forecast market size or the forecast market value of the cardiac marker testing market?

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $5.92 billion in 2023 to $6.52 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rise in geriatric population, rise in educational campaigns, increasing awareness, rising healthcare infrastructure, and rising patient population. The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $9.35 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising incidences of cardiovascular diseases, increasing strategic collaborations and partnerships, increasing research and development initiatives, favorable reimbursement policies and rising demand for point-of-care (POC) testing. Major trends in the forecast period include advanced diagnostic technologies, automated analyzers, advanced cardiac marker testing assays, digital health technologies, and emergence of integrative technologies. For further insights on the cardiac marker testing market, request a sample here

How is the cardiac marker testing market segmented?

The cardiac marker testing market is segmented
1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions For further insights on the cardiac marker testing market,
request a sample here

Which region has the largest share of the cardiac marker testing market? What are the other regions covered in the report?

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the cardiac marker testing market, request a sample here.

Who are the major players in the cardiac marker testing market?

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics For further insights on the cardiac marker testing market, request a sample here.

What are the key trends in the cardiac marker testing market?

Major trend in the cardiac marker testing market - Advancements In Cardiac Marker Testing. For further insights on the cardiac marker testing market, request a sample here.

What are the major opportunities in the cardiac marker testing market? What are the strategies for the cardiac marker testing market?

For detailed insights on the major opportunities and strategies in the cardiac marker testing market, request a sample here.

How does the cardiac marker testing market relate to the overall economy and other similar markets?

For detailed insights on cardiac marker testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cardiac marker testing industry?

For detailed insights on the mergers and acquisitions in the cardiac marker testing industry, request a sample here.

What are the key dynamics influencing the cardiac marker testing market growth? SWOT analysis of the cardiac marker testing market.

For detailed insights on the key dynamics influencing the cardiac marker testing market growth and SWOT analysis of the cardiac marker testing industry, request a sample here.